1. Personalizing Statin Therapy in Patients With HIV

3. Program Goals

4. Dyslipidemia in HIV Population

5. Contemporary ART: More Lipid Neutral

6. Risk of CVD in HIV

7. Continuous ART Reduces the Risk of CVD: SMART Study

8. Assessment of CV Risk in Patients With HIV

9. Atorvastatin Effects on ASCVD Progression in HIV Infection Reduced Plaque Progression vs Placebo

10. NLA Recommendations for Managing Dyslipidemia

11. REPRIEVE Trial: Assess Use of Statins as Primary Prevention of CVD in HIV

12. Use of Statins in Patients With HIV

13. Use of Statins With PIs

14. Effect of Statins on Markers of Immune Activation and Inflammation

15. Hypertriglyceridemia in HIV

16. Multidisciplinary Team Approach

17. Abbreviations

18. Abbreviations (cont)